President and CEO of CombiMatrix Corp. (CBMX, Financial) Amit Kumar buys 2,500 shares of CBMX on 08/17/2009 at an average price of $5.91 a share.
CombiMatrix Corporation is a diversified biotechnology business that develops proprietary technologies including products and services in potential markets where their products and services can be utilized. The Company\'s products and services are specially utilized in the areas of drug development genetic analysis molecular diagnostics nanotechnology and defense and homeland security markets. The technologies they have developed include a platform technology to rapidly produce user-defined in-situ synthesized oligonucleotide arrays for use in identifying and determining the roles of genes gene mutations and proteins. This technology has a wide range of potential applications in the areas of genomics proteomics biosensors drug discovery drug development diagnostics combinatorial chemistry material sciences and nanotechnology. Other technologies include proprietary molecular synthesis and screening methods for the discovery of potential new drugs. Combimatrix corp. has a market cap of $42.25 million; its shares were traded at around $5.66 with and P/S ratio of 6.75.
Recent Trades of CombiMatrix Corp. by CEO:
Recent Trades of CombiMatrix Corp. by Directors and Officers:
CombiMatrix Corporation is a diversified biotechnology business that develops proprietary technologies including products and services in potential markets where their products and services can be utilized. The Company\'s products and services are specially utilized in the areas of drug development genetic analysis molecular diagnostics nanotechnology and defense and homeland security markets. The technologies they have developed include a platform technology to rapidly produce user-defined in-situ synthesized oligonucleotide arrays for use in identifying and determining the roles of genes gene mutations and proteins. This technology has a wide range of potential applications in the areas of genomics proteomics biosensors drug discovery drug development diagnostics combinatorial chemistry material sciences and nanotechnology. Other technologies include proprietary molecular synthesis and screening methods for the discovery of potential new drugs. Combimatrix corp. has a market cap of $42.25 million; its shares were traded at around $5.66 with and P/S ratio of 6.75.
Recent Trades of CombiMatrix Corp. by CEO:
- Buy: President and CEO Amit Kumar bought 500 shares of CBMX stock on 06/08/2009 at the average price of $7.43; the price of the stock has decreased by 23.82% since.
- Buy: President and CEO Amit Kumar bought 500 more shares of CBMX stock on 06/02/2009 at the average price of $7.63; the price of the stock has decreased by 25.82% since.
- Buy: President and CEO Amit Kumar bought 1,000 more shares of CBMX stock on 03/18/2009 at the average price of $7.99; the price of the stock has decreased by 29.16% since.
Recent Trades of CombiMatrix Corp. by Directors and Officers:
- Buy: Director Scott Gottlieb bought 2,000 shares of CBMX stock on 05/28/2009 at the average price of $7.5; the price of the stock has decreased by 24.53% since.
